Astrazeneca Pharma India Ltd announced on October 16, 2026, a disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, regarding an Environmental, Social and Governance (“ESG”) rating assigned by NSE Sustainability Ratings and Analytics Limited, which is 73 for the financial year 2025-26; the company notes it did not engage NSE Sustainability Ratings and Analytics Limited, and the rating was independently prepared based on publicly available information, with no enhancements, assignments, or withdrawals related to any instruments.